NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The Case for PGT-A, Preventing Avoidable Suffering in Assisted Reproduction! – Collectif BAMP Association
Collectif BAMP Association/LinkedIn
Jun 4, 2026, 16:01

The Case for PGT-A, Preventing Avoidable Suffering in Assisted Reproduction! – Collectif BAMP Association

Collectif BAMP Association shared a post on LinkedIn:

“Never worn, like their baby

In France, 75% of embryos transferred in assisted reproduction do not result in a live birth.

In many cases, because the embryos are not viable.

The result: long journeys, heavy treatments, repeated failures, miscarriages, medical terminations of pregnancy.

Suffering that could be avoided if PGD-A were authorized.

PGD-A is a test that identifies non-viable embryos before they are transferred. It is authorized in the majority of European countries.

In France, it remains banned.

While the 2026 General Assembly on Bioethics puts these issues back at the heart of the public debate, today we are launching ‘Jamais Portés’  a campaign to call for the legalization of PGD-A.

Sign the petition

Discover the announcements

Thank you to the entire The Good Company team and the talented photographer Valérie Archeno

Samir HAMAMAH.”

Proceed to the video attached to the post.

Stay updated on all scientific advances in the field of fertility with Fertility News.

Collectif BAMP Association Embryos Fertility Fertility News General Assembly on Bioethics heavy treatments live birth long journeys medical terminations Miscarriages PGD-A repeated failures reproductive health Reproductive Medicine The Good Company Valérie Archeno
NewsFeed